AUTHOR=Däster Silvio , Eppenberger-Castori Serenella , Mele Valentina , Schäfer Hannah M. , Schmid Lukas , Weixler Benjamin , Soysal Savas D. , Droeser Raoul A. , Spagnoli Giulio C. , Kettelhack Christoph , Oertli Daniel , Terracciano Luigi , Tornillo Luigi , von Holzen Urs TITLE=Low Expression of Programmed Death 1 (PD-1), PD-1 Ligand 1 (PD-L1), and Low CD8+ T Lymphocyte Infiltration Identify a Subgroup of Patients With Gastric and Esophageal Adenocarcinoma With Severe Prognosis JOURNAL=Frontiers in Medicine VOLUME=7 YEAR=2020 URL=https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2020.00144 DOI=10.3389/fmed.2020.00144 ISSN=2296-858X ABSTRACT=
Prognosis of gastric and esophageal cancer is poor and treatment improvements are needed. Programmed cell death 1 receptor (PD-1) interaction with its ligand PD-L1 in tumor micro-environment promotes immune tolerance and blocking monoclonal antibodies have entered clinical practice. However, clinical significance of PD-1 and PD-L1 expression in gastric and esophageal adenocarcinomas, particularly in non-Asian patients, is still unclear. Three tissue microarrays including 190 clinically annotated esophageal (